Kuala Lumpur, 7 April 2026 – Government-linked private equity firm Ekuiti Nasional Bhd (Ekuinas) has acquired a strategic minority stake in Kelantan-based pharmaceutical manufacturer Ain Medicare to support its next phase of growth, following earlier expansion funding from VentureTECH between 2017 and 2025. Founded in 1993, Ain Medicare operates seven manufacturing facilities in Kelantan and Kulim, employs around 1,400 staff, and specialises in sterile injectable products such as intravenous solutions and haemodialysis concentrates, supplying both domestic healthcare providers and 17 international markets across multiple regions. The investment, drawn from Ekuinas’ RM1 billion (approximately EUR 221.83 million) fund, aligns with Malaysia’s broader Bumiputera development agenda and aims to strengthen local participation in the high-value pharmaceutical sector, while building on Ain Medicare’s established 30-year track record, R&D capabilities, and growing export footprint.Source - https://theedgemalaysia.com/node/798857 (ICE KUALA LUMPUR)

Fonte notizia: 7 aprile 2026, Kuala Lumpur